Business Wire

Wolters Kluwer Launches AI-enhanced UpToDate Enterprise Edition in EMEA

4.6.2025 15:30:00 CEST | Business Wire | Press Release

Share

Wolters Kluwer Health today announced its UpToDate® Enterprise Edition will be available to healthcare systems and hospitals in the Europe, Middle East, and Africa (EMEA) region beginning in Q3. Designed specifically for large healthcare systems and hospitals, the clinical decision support (CDS) solution, which features AI enhancements, is designed to support healthcare administrators and clinicians to help deliver consistently high-quality care. Wolters Kluwer Health will demonstrate the solution at HIMSS25 Europe in Paris, June 10-12, 2025.

“Leveraging AI technology, UpToDate Enterprise Edition goes beyond traditional decision support to provide unparalleled quality that supports streamlined, integrated workflows and faster time-to-answers, ultimately fostering patient engagement and transforming care delivery,” said Christian Cella, Vice President, International Segment for Clinical Effectiveness at Wolters Kluwer Health. “With UpToDate Enterprise becoming available in EMEA, we are extending Wolters Kluwer’s commitment to enhancing clinical decision-making worldwide.”

For decades, healthcare professionals around the world have trusted UpToDate clinical decision support to enable confident decision-making and reduce variability in care. The UpToDate Enterprise Edition solution builds on that value to include advanced features, insights, and technology innovations to help them meet these current and emerging industry challenges. The solution is in early release at 40 of the largest health systems in EMEA joining the over 350 health systems in North America using the UpToDate Enterprise Edition.

“UpToDate has been an extremely valuable clinical decision support resource for Icelandic health institutions. UpToDate Enterprise Edition adds new features including AI that will aid our staff to make smarter clinical decisions to further help improve patient care,” says Runólfur Pálsson, CEO of Landspítali University Hospital and Professor of Medicine at the Faculty of Medicine of the University of Iceland.

UpToDate Enterprise Edition offers harmonized content and solutions for the entire care team, empowering them to make more informed, confident, and impactful decisions. With its AI-Enhanced Search capabilities, clinicians can now experience the efficiency of receiving highly focused verbatim answers from a market leading clinical decision solution using natural language queries—a time-saver for busy healthcare professionals. The AI-powered Analytics Dashboard offers healthcare organizations the ability to harness valuable organizational data for improved efficiency and educational opportunities.

“Deploying UpToDate Enterprise Edition is an important initiative in supporting our digital innovation strategy,” said Professor Adrian Harris, Chief Medical Officer at the Royal Devon University Healthcare NHS Foundation Trust. “By leveraging the data, analytics and AI capabilities now available within UpToDate, we can further support medical education and optimize clinical decision making, helping us deliver the best possible care for all patients and enabling our local population to stay well.”

This enhanced solution unifies care teams and administrators with a focus on workflow innovation, analytics, and advanced care features. With access across teams, organizations can:

  • Manage complexity by advancing clinical decisions
  • Enhance satisfaction and collaboration by aligning all members of the care team to the same trusted UpToDate content with advanced decision-making features
  • Help alleviate burnout through improved workflow capabilities
  • Improve resource utilization and business outcomes via system-wide data and insights and self-service analytics, such as system-wide topic usage, UpToDate topic benchmarking, and CME accreditation activity.

In the Frost Radar™: Clinical Decision Support System, 2025report, Wolters Kluwer was the only one named both a “Company to Action” and the market leader for innovation. Frost & Sullivan screened and analyzed more than 60 clinical decision support vendors across point-of-care segments and short-listed 10 companies based on a detailed analysis of their corporate growth potential and ability to drive visionary innovation in this space.

Learn more about UpToDate Enterprise Edition in EMEA.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250604785080/en/

Contacts

Media Contact
Suzanne Moran
Associate Director, External Communications
Health
Wolters Kluwer
Office/Mobile: +1 6178938586
Suzanne.Moran@Wolterskluwer.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press Release

EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres

Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release

Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re

Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press Release

Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoint, demonstrating non-inferiority

Tigo Energy Improves Installer Choice via Fronius Compatibility with TS4 Product Line22.10.2026 18:02:00 CEST | Press Release

Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a manufacturer declaration of compatibility from Fronius International GmbH, documenting compatibility between Tigo Flex MLPE products and multiple Fronius inverter families. The letter covers Tigo TS4-A-F, TS4-A-2F, TS4-A-O, and TS4-X-O products and the Fronius Primo GEN24, Primo GEN24 208-240, Symo GEN24, Verto, Tauro, and Tauro ECO inverter families, when configured according to the requirements specified by Fronius and Tigo. Building on established compatibility in Europe, the declaration extends manufacturer-confirmed compatibility to markets worldwide, including the United States and Canada, giving solar professionals greater flexibility to design high-quality systems using manufacturer-confirmed technology combinations. Fronius develops solar technologies and solutions for residential, commercial, and large-scale applications, with a port

Saudi Maritime & Logistics Congress Highlights Maritime Sector Integration and Opportunities for Trade and Investment Growth in the Kingdom22.10.2026 16:52:00 CEST | Press Release

The Saudi Maritime & Logistics Congress highlighted Saudi Arabia’s role in supporting the continuity of trade flows and strengthening supply chain resilience as it opened at Jeddah Superdome, bringing together representatives of government entities, maritime transport and logistics leaders, and the business community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022362613/en/ The Congress takes place as rapid changes in trade and shipping prompt companies to reassess transport routes and operational and investment choices. It provides a platform for dialogue among stakeholders to explore opportunities for cooperation and strengthen integration between ports and maritime, land transport and logistics services, supporting operational efficiency and supply chain reliability. In his opening address, His Excellency Eng. Fawaz Alsahli, President of the Transport General Authority in Saudi Arabia, emphasised that the Kingdom’s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye